Elena García-Martínez

Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer

Elena García-Martínez, Ginés Luengo‐Gil, Asunción Chaves Benito et al. · Breast Cancer Research · 2014 · 254 citations · Full text

Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer

Yolanda García García, Ana de Juan Ferré, César Mendiola et al. · International Journal of Gynecological Cancer · 2019 · 55 citations

Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis

Miguel Martín, José Ignacio Chacón, Antonio Antón et al. · The Oncologist · 2017 · 26 citations · Full text

Phase II randomized trial of neoadjuvant (NA) chemotherapy (CT) with or without bevacizumab (Bev) in advanced epithelial ovarian cancer (EOC) (GEICO 1205/NOVA TRIAL).

Yolanda García García, Ana De Juan, César Mendiola et al. · Journal of Clinical Oncology · 2015 · 15 citations

Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study

Miguel Gil‐Gil, Meritxell Bellet, Milana Bergamino et al. · Frontiers in Oncology · 2021 · 13 citations · Full text